These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4300395)

  • 1. Augmented sympathetic neurotransmitter activity in the peripheral vascular bed of patients with congestive heart failure and cardiac norepinephrine depletion.
    Kramer RS; Mason DT; Braunwald E
    Circulation; 1968 Oct; 38(4):629-34. PubMed ID: 4300395
    [No Abstract]   [Full Text] [Related]  

  • 2. Alterations of cardiac sympathetic neurotransmitter activity in congestive heart failure.
    Rutenberg HL; Spann JF
    Am J Cardiol; 1973 Sep; 32(4):472-80. PubMed ID: 4147109
    [No Abstract]   [Full Text] [Related]  

  • 3. Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure.
    Levine TB; Francis GS; Goldsmith SR; Simon AB; Cohn JN
    Am J Cardiol; 1982 May; 49(7):1659-66. PubMed ID: 7044086
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of experimental heart failure on peripheral sympathetic vasoconstriction.
    Wilson JR; Matthai W; Lanoce V; Frey M; Ferraro N
    Am J Physiol; 1988 Apr; 254(4 Pt 2):H727-33. PubMed ID: 3354699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure.
    Leimbach WN; Wallin BG; Victor RG; Aylward PE; Sundlöf G; Mark AL
    Circulation; 1986 May; 73(5):913-9. PubMed ID: 3698236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal neurohumoral response to nitroprusside infusion in congestive heart failure.
    Olivari MT; Levine TB; Cohn JN
    J Am Coll Cardiol; 1983 Sep; 2(3):411-7. PubMed ID: 6875105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fine structural identification of a reserpine-resistant norepinephrine store in adrenergic nerve terminals in guinea-pig atria.
    Van Orden LS; Schaefer JM; Antonaccio MJ; Smith CB
    J Pharmacol Exp Ther; 1974 Mar; 188(3):668-75. PubMed ID: 4131521
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiac sympathetic nervous activity in congestive heart failure. Evidence for increased neuronal norepinephrine release and preserved neuronal uptake.
    Meredith IT; Eisenhofer G; Lambert GW; Dewar EM; Jennings GL; Esler MD
    Circulation; 1993 Jul; 88(1):136-45. PubMed ID: 8391399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in norepinephrine levels in different vascular beds in congestive heart failure.
    Eichhorn EJ; Hatfield BA; Marcoux L
    Am J Cardiol; 1993 Feb; 71(5):442-6. PubMed ID: 8430636
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiac sympathetic nerve function in congestive heart failure.
    Eisenhofer G; Friberg P; Rundqvist B; Quyyumi AA; Lambert G; Kaye DM; Kopin IJ; Goldstein DS; Esler MD
    Circulation; 1996 May; 93(9):1667-76. PubMed ID: 8653872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral circulatory control mechanisms in congestive heart failure.
    Zelis R; Longhurst J; Capone RJ; Lee G
    Am J Cardiol; 1973 Sep; 32(4):481-90. PubMed ID: 4580961
    [No Abstract]   [Full Text] [Related]  

  • 12. Sympathetic activation in congestive heart failure: reproducibility of neuroadrenergic markers.
    Grassi G; Bolla G; Quarti-Trevano F; Arenare F; Brambilla G; Mancia G
    Eur J Heart Fail; 2008 Dec; 10(12):1186-91. PubMed ID: 18851926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure.
    Brunner-La Rocca HP; Esler MD; Jennings GL; Kaye DM
    Eur Heart J; 2001 Jul; 22(13):1136-43. PubMed ID: 11428854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased central nervous system monoamine neurotransmitter turnover and its association with sympathetic nervous activity in treated heart failure patients.
    Lambert GW; Kaye DM; Lefkovits J; Jennings GL; Turner AG; Cox HS; Esler MD
    Circulation; 1995 Oct; 92(7):1813-8. PubMed ID: 7545554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antagonism of phentolamine against exogenously administered and endogenously released norepinephrine in rabbit aortic strips.
    Urquilla PR; Stitzel RE; Fleming WW
    J Pharmacol Exp Ther; 1970 Apr; 172(2):310-9. PubMed ID: 4315002
    [No Abstract]   [Full Text] [Related]  

  • 16. Heart rate variability measurement correlates with cardiac norepinephrine spillover in congestive heart failure.
    Tygesen H; Rundqvist B; Waagstein F; Wennerblom B
    Am J Cardiol; 2001 Jun; 87(11):1308-11. PubMed ID: 11377364
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiac noradrenergic nerve terminal abnormalities in dogs with experimental congestive heart failure.
    Himura Y; Felten SY; Kashiki M; Lewandowski TJ; Delehanty JM; Liang CS
    Circulation; 1993 Sep; 88(3):1299-309. PubMed ID: 8102598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The release of noradrenaline from sympathetic fibres in relation to calcium concentration.
    Burn JH; Gibbons WR
    J Physiol; 1965 Nov; 181(1):214-23. PubMed ID: 5866284
    [No Abstract]   [Full Text] [Related]  

  • 19. [Modulation of norepinephrine release in sympathetic nerve endings in renal hypertensive dogs].
    Xu B; Chen RX; Chen DG; Zhang L; Li JM
    Zhongguo Yao Li Xue Bao; 1990 Sep; 11(5):438-41. PubMed ID: 1983375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Norepinephrine depletion in idiopathic orthostatic hypotension.
    Kontos HA; Richardson DW; Norvell JE
    Ann Intern Med; 1975 Mar; 82(3):336-41. PubMed ID: 1115467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.